Virtu Financial’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Buy
+17,000
New +$502K 0.02% 469
2025
Q4
Sell
-12,423
Closed -$188K 2148
2025
Q3
$188K Buy
+12,423
New +$154K 0.01% 930
2024
Q4
Sell
-17,917
Closed -$207K 1978
2024
Q3
$207K Buy
+17,917
New +$204K 0.01% 785
2024
Q1
Sell
-12,118
Closed -$136K 1989
2023
Q4
$136K Buy
+12,118
New +$118K 0.01% 955
2022
Q1
Sell
-20,163
Closed -$203K 1954
2021
Q4
$203K Buy
+20,163
New +$168K 0.02% 831

Other funds holding ROIV

Virtu Financial's ROIV Position: Q2 2026 in Review

Virtu Financial opened a new position in Roivant Sciences (ROIV) in Q2 2026: 17,000 shares worth $602K. The stake represents 0.02% of the portfolio and ranks #469 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ROIV as recently as Q3 2025.

Virtu Financial first reported a position in ROIV in Q4 2021 and has held it in 5 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Virtu Financial held 17,000 shares of Roivant Sciences worth $602K as of Q2 2026.
  • Roivant Sciences was a new Virtu Financial position in Q2 2026.
  • Roivant Sciences made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #469 holding.
  • Virtu Financial first reported a position in Roivant Sciences in Q4 2021 and has held it in 5 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.